Company intelligence / Profile preview
Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
Overview
Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant (now known as Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited No. 6 Chinese Medicine Plant) is a leading Chinese pharmaceutical manufacturer specializing in modern traditional Chinese medicine (TCM) dripping pills. Founded in 1958 and based in Tianjin, China, the plant is renowned as the first GMP-certified TCM enterprise in China and the country's only 'TCM Dripping Pill Quality Management Demonstration Base.' Its flagship product, Suxiao Jiuxin Pill (速效救心丸), is a national-level confidential formula widely used for the emergency treatment of coronary heart disease and angina pectoris. The company also produces other notable TCM dripping pill products, including Shunaoxin Dripping Pills for migraines and Qingyan Dripping Pills for throat irritation. Utilizing advanced automated manufacturing technologies, the plant integrates traditional herbal medicine with modern pharmaceutical standards.
- Therapeutic areas
- Infectious DiseasesOtherNeurologyCardiovascularPulmonology
- Modalities
- Herbal medicineBotanical extractPlant extract
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant.